Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials
収録刊行物
-
- The Lancet Oncology
-
The Lancet Oncology 21 (2), 271-282, 2020-02
Elsevier BV